Refine by
Diagnostic Development Suppliers Serving Myanmar
125 companies found
based inVienna, AUSTRIA
We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA ...
based inBurlingame, CALIFORNIA (USA)
Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis. This test has not yet been ...
based inCarlsbad, CALIFORNIA (USA)
Toolbox Medical Innovations develops and manufactures life science and diagnostic products with a focus on in vitro diagnostics (IVD). We help our clients quickly turn their technologies into user-friendly, cost-effective, and clinically validated ...
Blister pack technology allows onboard delivery of diagnostic reagents into a receiving well on a microfluidic chip where they can be dispersed through channels. The process of incorporating blisters onto a microfluidic cartridge may seem simple. ...
based inKävlinge, SWEDEN
The Genovis Group consists of Genovis AB, Sweden, and the wholly owned subsidiary Genovis Inc., USA. The company's shares are listed on Nasdaq First North Growth Market. Genovis’ business concept is to offer customers in the biopharmaceutical and ...
based inPoway, CALIFORNIA (USA)
Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver ...
based inValladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
based inSan Francisco, CALIFORNIA (USA)
Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and biosensor enabling technologies for preclinical drug discovery & development, biobanking, in vitro diagnostics, and biomarker development. Our ...
based inHangzhou City, CHINA
Cnpair Biotech Co., Ltd. is a professional provider which concentrates on IVD core materials, including antibodies and proteins, and we are dedicated to developing and delivering highly competitive antibodies and proteins with outstanding ...
based inZhubei, TAIWAN
QuarkBio strives to become a global leader in providing high quality precision healthcare solutions to our partners through our core technologies by maintaining a strong connection between the latest research findings and the needs of both doctors ...
Choose NextAmp™ Analysis System to optimize biomarker selection and to accelerate the clinical research towards next precision medicine ...
based inGuangdong, CHINA
Fapon Biotech Inc., founded in 2001, adheres to the mission of “Enable Disease Identification Earlier, More Accurate, Convenient and Affordable”, while focusing on the future needs and trends of biotechnology development, and committed to providing ...
based inSt. Louis, MISSOURI (USA)
C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...
The PrecivityAD® Blood Test Answers Calls from Patients, Advocates, and Healthcare Providers Who Want Earlier Answers. Summary of Test and Patient Selection. The PrecivityAD® test identifies whether a patient is likely to have the presence ...
based inSaint Paul, MINNESOTA (USA)
Since 1977, we’ve been dedicated to cardiorespiratory health solutions. Headquartered in Saint Paul, Minnesota, USA, MGC Diagnostics Corporation, develops, manufactures and markets non-invasive diagnostic systems for detecting, classifying and ...
based inLincolnshire, ILLINOIS (USA)
Sysmex America, Inc. distributes and supports automated in vitro diagnostic hematology, flow cytometry, technology solutions, coagulation and urinalysis analyzers, reagents and information systems for laboratories and healthcare facilities in North ...
based inBerlin, GERMANY
We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high ...
based inOklahoma City, OKLAHOMA (USA)
By launching first-in-market biomarker tests and developing digital biomarkers for the continuous monitoring of disease, we support clinicians in their effort to provide exceptional care. Our technologies will empower clinician decision making and ...
based inDurham,, NORTH CAROLINA (USA)
Founded in 1998, Cancer Diagnostics, Inc. (CDI) is a leading developer and manufacturer of histology, cytology, surgical pathology and immunohistochemistry diagnostic supplies. CDI developed the first commercially available 7-dye color kit for ...
based inEast Brisbane, AUSTRALIA
Ellume is a digital diagnostics company that develops, manufactures, and commercializes high-performance, connected products for healthcare professionals and consumers. It is at the forefront of accurate, rapid and accessible testing that is ...
based inLa Jolla, CALIFORNIA (USA)
Liferiver is a leading PCR-based molecular diagnostics solution provider, developing, manufacturing & marketing real time PCR diagnostic kits as well as instruments. We offer over 400 testing kits covering most infectious diseases, genetic diseases, ...
based inBaoshan, CHINA
Established in 1989, Shanghai Fosun Long March Medical Science Co., Ltd (herein after as Fosun Long March) is a high tech in-vitro diagnostics enterprise who is active in manufacturing, marketing and research and development of diagnostic and ...
based inVienna, AUSTRIA
Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH was founded in 1987 by Prof. Dr. Bernd R. Binder (1945 - 2010). The main focus of the company was on monoclonal antibodies against components of the coagulation and the fibrinolytic ...
